SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
23-Oct-17 4:59 PM View: | Aravive, Inc. (ARAV) | 19-Oct-17 | Market Sale | 667 | $2.55 | $1,700.85 | (3%) 24.5K to 23.83K | 57% |
05-Apr-17 7:02 PM View: | Aravive, Inc. (ARAV) | 04-Apr-17 | Option Exercise | 35,000 | $8.17 | $285,950.00 | 143% 24.5K to 59.5K | |
05-Apr-17 7:02 PM View: | Aravive, Inc. (ARAV) | 04-Apr-17 | Market Option Sale (Planned) | 35,000 | $21.20 | $742,000.00 | (59%) 59.5K to 24.5K | 95% |
31-Jan-17 8:32 PM View: | Aravive, Inc. (ARAV) | 27-Jan-17 | Grant | 19,500 | -- | -- | 390% 5.0K to 24.5K | |
13-Oct-16 5:58 PM View: | Aravive, Inc. (ARAV) | 11-Oct-16 | Grant | 5,000 | -- | -- | 100% 0 to 5.0K | |
18-Nov-15 6:53 PM View: | Anthera Pharmaceuticals Inc (ANTH) | 13-Nov-15 | Option Exercise | 12,500 | $1.61 | $20,125.00 | 59% 21.04K to 33.54K | |
18-Nov-15 6:53 PM View: | Anthera Pharmaceuticals Inc (ANTH) | 13-Nov-15 | Market Option Sale | 12,500 | $5.31 | $66,341.20 | (37%) 33.54K to 21.04K | 100% |
12-Nov-15 4:21 PM View: | Anthera Pharmaceuticals Inc (ANTH) | 11-Nov-15 | Market Sale | 5,000 | $5.38 | $26,900.00 | (19%) 26.04K to 21.04K | 100% |
27-Mar-14 9:58 PM View: | Anthera Pharmaceuticals Inc (ANTH) | 25-Mar-14 | Grant | 3,864 | -- | -- | 15% 25.5K to 29.37K | |
27-Mar-14 9:58 PM View: | Anthera Pharmaceuticals Inc (ANTH) | 25-Mar-14 | Payment of Exercise | 3,323 | -- | -- | (11%) 29.37K to 26.04K | |
27-Mar-13 9:19 PM View: | Anthera Pharmaceuticals Inc (ANTH) | 25-Mar-13 | Grant | 59,132 | -- | -- | 59% 100.14K to 159.27K | |
07-Jan-13 9:17 PM View: | Anthera Pharmaceuticals Inc (ANTH) | 03-Jan-13 | Payment of Exercise | 4,560 | $0.69 | $3,146.40 | (4%) 104.7K to 100.14K | 100% |
27-Feb-12 5:26 PM View: | Anthera Pharmaceuticals Inc (ANTH) | 23-Feb-12 | Option Exercise | 40,000 | $0.26 | $10,400.00 | 73% 54.7K to 94.7K | |
06-Feb-12 8:04 PM View: | Anthera Pharmaceuticals Inc (ANTH) | 06-Feb-12 | Grant | 9,923 | -- | -- | 14% 72.75K to 82.67K | |
06-Feb-12 8:04 PM View: | Anthera Pharmaceuticals Inc (ANTH) | 03-Feb-12 | Market Sale (Planned) | 30,000 | $8.20 | $246,000.00 | (29%) 102.75K to 72.75K | 100% |
10-Nov-11 5:06 PM View: | Anthera Pharmaceuticals Inc (ANTH) | 08-Nov-11 | Option Exercise | 15,000 | $0.26 | $3,900.00 | 21% 73.15K to 88.15K | |
10-Nov-11 5:06 PM View: | Anthera Pharmaceuticals Inc (ANTH) | 08-Nov-11 | Market Option Sale | 15,000 | $6.74 | $101,163.00 | (17%) 88.15K to 73.15K | 100% |
14-Jul-11 4:15 PM View: | Anthera Pharmaceuticals Inc (ANTH) | 12-Jul-11 | Option Exercise | 15,000 | $0.26 | $3,900.00 | 26% 58.15K to 73.15K | |
05-Jul-11 6:28 PM View: | Anthera Pharmaceuticals Inc (ANTH) | 30-Jun-11 | Payment of Exercise | 17,500 | $8.17 | $142,975.00 | (23%) 75.65K to 58.15K | 100% |
30-Jun-11 8:06 PM View: | Anthera Pharmaceuticals Inc (ANTH) | 29-Jun-11 | Option Exercise | 10,000 | $0.26 | $2,600.00 | 15% 65.25K to 75.25K | |
14-Feb-11 10:00 PM View: | Anthera Pharmaceuticals Inc (ANTH) | 11-Feb-11 | Purchase | 3,894 | -- | -- | 6% 61.35K to 65.25K | |
23-Sep-10 8:40 PM View: | Anthera Pharmaceuticals Inc (ANTH) | 21-Sep-10 | Option Exercise | 14,683 | $0.26 | $3,817.58 | 32% 46.34K to 61.02K | |
20-Aug-10 2:37 PM View: | Anthera Pharmaceuticals Inc (ANTH) | 18-Aug-10 | Market Purchase | 500 | $4.80 | $2,399.80 | 1% 45.84K to 46.34K | (100%) |
02-Jul-10 6:59 PM View: | Anthera Pharmaceuticals Inc (ANTH) | 30-Jun-10 | Grant | 40,000 | -- | -- | 685% 5.84K to 45.84K |